Hunting Hill Global Capital’s ESSA Pharma EPIX Stock Holding History

Hunting Hill Global Capital’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$30.9K	–	131
2023 Q3	$30.9K	Hold	10,000	–	–	0.01%	93
2023 Q2	$27K	Hold	10,000	–	–	0.01%	90
2023 Q1	$29.7K	Sell	10,000 -10,000	-50%	-$29.4K	0.02%	54
2022 Q4	$50.4K	Buy	20,000 +10,000	+100%	+$28.7K	0.03%	63
2022 Q3	$18K	Buy	+10,000	New	+$26.4K	0.01%	70

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Hunting Hill Global Capital's EPIX Position: Q4 2023 in Review

Hunting Hill Global Capital sold out of ESSA Pharma (EPIX) in Q4 2023, closing a stake of 10,000 shares — an estimated $30.9K sold.

Hunting Hill Global Capital first reported a position in EPIX in Q3 2022 and held it in 5 quarters. The position peaked at $50.4K in Q4 2022. 31 funds tracked by Wall St. Rank hold EPIX as of Q4 2023.

Hunting Hill Global Capital reported no remaining ESSA Pharma position as of Q4 2023 after selling out during the quarter.
Hunting Hill Global Capital sold 10,000 ESSA Pharma shares in Q4 2023, an estimated $30.9K.
Hunting Hill Global Capital first reported a position in ESSA Pharma in Q3 2022 and held it in 5 quarters.
Hunting Hill Global Capital's ESSA Pharma position peaked at $50.4K in Q4 2022.
31 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2023.

Based on Hunting Hill Global Capital's 13F filing for Q4 2023, filed 14 Feb 2024.